Rainer Spanagel
Project Coordinator Rainer Spanagel, PhD
Full professor, Scientific Director Institute of Psychopharmacology, Heidelberg University
List of relevant publications and Patents within the last five years
Total publications 1990-2018: 298 PubMed listed with 5 Highly Cited Publication in Field. Sum of the times cited:
14.750 (WEB of Science, March 2018) - H-Index: 65
Spanagel R, Vengeliene V, Jandeleit B, …, Lawrence AJ, Kiefer F (2014) Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology 39:783-91.
Vengeliene V, Noori HR, Spanagel R (2015) Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption. Neuropsychopharmacology 40:2897-906.
Hirth N, Meinhardt MW, …, Perreau-Lenz S, Sommer WH, Spanagel R*, Hansson AC* (2016) Convergent evidence from alcohol dependent humans and rats for a hyperdopaminergic state in protracted abstinence. Proc Natl Acad Sci U S A 113:3024-29 *equal contribution
Noori HR, Schöttler J, Ercsey-Ravasz M, Cosa-Linan A, Varga M, Toroczkai Z, Spanagel R (2017) A multiscale cerebral neurochemical connectome of the rat brain. PLoS Biol 15(7):e2002612.
Hansson AC, Koopmann A, Uhrig S, Bühler S, Domi E, Kiessling E, Ciccocioppo R, Froemke RC, Grinevich V, Kiefer F, Sommer WH, Vollstädt-Klein S, Spanagel R (2018) Oxytocin Reduces Alcohol Cue-Reactivity in Alcohol-Dependent Rats and Humans. Neuropsychopharmacology 43:1235-1246.
EU patent (2016) (Noori HR, Mücksch C, Urbassek HM, Spanagel R: “Mutated Receptor Polypeptide and Use Thereof”
EU Patent Application No 14155868.4.
ONGOING GRANTS RELATED TO THE PRESENT TOPIC (No overlaps with the pre-proposal)
DFG SFB1134 Neuronal Ensembles in Reward Processing 2014-2018
EU SyBil-AA in Horizon 2020: Systems Biology of Alcohol Addiction 2015-2019
BMBF e:Med: Alcohol Addiction - A Systems-Oriented Approach 2014-2019
EDUCATION
1991 PhD, Neuropharmacology, Max Planck Institute of Neuropharmacology (Prof. Albert Herz) Martinsried, Germany
1991 – 1995 Scientific assistant, MPI of Psychiatry, Munich (Prof. Florian Holsboer)
1996 Habilitation, Pharmacology & Toxicology (Prof. Wolfgang Forth) University of Munich
1995 – 1999 Head of the Research Group “Drug Addiction” at the MPI of Psychiatry
2000 – Scientific Director of the Institute of Psychopharmacology, CIMH
awards
1998 Wilhelm Feuerlein Award for Alcohol Research
2003 Sir Hans Krebs Award
2005 Albrecht-Ludwig-Berblinger Award
2008 James B. Isaacson Award
2010 Reinhart-Koselleck-Award, DFG
2011 AGNP Award for Excellence in Psychopharmacology
2015 NEATOR Award from American College of
Neuropsychopharmacology
2017 European Alcohol Research Award from ESBRA and
Lautenschläger Foundation
2018 BANGS Distinguished Investigator Award
comissions of trust
2005 – Editor-in-Chief of Addiction Biology
2003 – Member of the Editorial Boards of Addiction (2003-
2009), Alcoholism Clinical and Experimental Research (2003-2017), Behavioural Brain Research (since 2011), Journal of Neurochemistry (since 2014), International Journal of Neuropsychopharmacology (since 2015), Naunyn-Schmiedeberg's Archives of Pharmacology (since 2016), Genes (since 2016)
2004 – Member of the Executive Board of the Society of Addiction (SSA)
2008 – 2010 Management Board National Genome Research Network (NGFN)
2009 – 2017 Scientific Advisory Board ECNP
2014 – 2016 Management Board of the National e:Med Consortia on Systems Medicine
2014 – 2020 Scientific Advisory Board of the EMCDDA in Lisbon
2016 – 2018 President of the International Society of Biomedical Research on Alcoholism (ISBRA)